Blistering, erosions and scarring in a patient on etretinate.
A case is reported of a patient who developed blistering of the skin followed by ulceration and scarring while on treatment with etretinate.
Ramsay
B
B
University Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.
Bloxham
C
C
Eldred
A
A
Munro
C
C
Marks
J
J
D001768:Blister / Q000139:chemically induced*; D002921:Cicatrix / Q000139:chemically induced*; D003875:Drug Eruptions / Q000097:blood / Q000209:etiology*; D005050:Etretinate / Q000009:adverse effects* / Q000097:blood; D005260:Female; D006801:Humans; D008875:Middle Aged; D012883:Skin Ulcer / Q000139:chemically induced*
D005050:Etretinate